Stephen L. Seagren

3.7k citations
44 papers · 2.8k indexed · 2 hit papers · h-index 18
Topics
Lung Cancer Treatments and Mutations (19 papers)Lung Cancer Diagnosis and Treatment (17 papers)Lung Cancer Research Studies (13 papers)
Partner nations
United StatesCanada

In The Last Decade

Stephen L. Seagren

42 papers receiving 2.7k citations

Hit Papers

A Randomized Trial of Induction Chemotherapy plus High-Do...199020262002201419901996250500750

Peers

Stephen L. Seagren
Comparison fields: 5 of 82
  • Pulmonary and Respiratory Medicine 2.1k
  • Oncology 1.4k
  • Otorhinolaryngology 623
  • Surgery 559
  • Radiation 415
Replace Signe Friesland with:
Signe Friesland Sweden
W. Van den Bogaert Belgium
F. Adab United Kingdom
Rafael Martínez‐Monge Spain
F. Eschwège France
J. Bernier Switzerland
Yeon‐Sil Kim South Korea
Antoine Lusinchi France
Yuzuru Niibe Japan
D. Chassagne France
Stephen L. Seagren relative to Signe Friesland Sweden Signe Friesland's profile →
Citations per field
00.5×1.5×2.0×
Signe Friesland · 1×
Citations per year

Countries citing papers authored by Stephen L. Seagren

Since Specialization
Citations

This map shows the geographic impact of Stephen L. Seagren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen L. Seagren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen L. Seagren more than expected).

Fields of papers citing papers by Stephen L. Seagren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen L. Seagren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen L. Seagren. The network helps show where Stephen L. Seagren may publish in the future.

Co-authorship network of co-authors of Stephen L. Seagren

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen L. Seagren. A scholar is included among the top collaborators of Stephen L. Seagren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen L. Seagren. Stephen L. Seagren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 4
2 6
3 3
4 6
5 56
6 136
7 17
8 52
9
Improved Survival in Stage III Non-Small-Cell Lung Cancer: Seven-Year Follow-up of Cancer and Leukemia Group B (CALGB) 8433 Trialbreakdown →
709
10 70
11 125
12 21
13 142
14 13
15 1
16
A Randomized Trial of Induction Chemotherapy plus High-Dose Radiation versus Radiation Alone in Stage III Non-Small-Cell Lung Cancerbreakdown →
882
17
Radical radiation therapy for lung cancer.
5
18 24
19 23
20 12

About Stephen L. Seagren

Stephen L. Seagren is a scholar working on Otorhinolaryngology, Pulmonary and Respiratory Medicine and Oncology, having authored 44 papers that have together received 2.8k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (19 papers), Lung Cancer Diagnosis and Treatment (17 papers) and Lung Cancer Research Studies (13 papers). The work is most often cited by research in Otorhinolaryngology (623 citations), Pulmonary and Respiratory Medicine (2.1k citations) and Oncology (1.4k citations). Stephen L. Seagren has collaborated with scholars based in United States and Canada. Frequent co-authors include Walter L. Eaton, James E. Herndon, R O Dillman, Robert W. Carey, Robert O. Dillman, Mark R. Green, Michael C. Perry, Kathleen J. Propert, Emil Frei and Julio Guerra. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026